Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Women with early onset androgenetic alopecia have worse lipid profiles.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.